Yahoo Finance AMN Healthcare Inks Deal to Address Healthcare System Needs
AMN Healthcare Services, Inc. AMN recently inked a partnership with Randstad US to deliver the first comprehensive suite of workforce solutions for the healthcare community. These solutions address needs like direct patient care, allied services, and professional and technical support.
For investors’ notice, Randstad US is a leading provider of flexible work and human resource solutions.
This partnership is expected to boost AMN Healthcare’s Other Workforce Solutions segment.
More About the Partnership
AMN Healthcare and Randstad US’ Integrated Talent Solutions offer simplified and streamlined technology-enabled services to aid healthcare organizations alleviate the burden of complex talent strategies, now and in the future. With the combination of AMN Healthcare's unparalleled expertise in clinical staffing and Randstad's vast suite of non-clinical human resources, this partnership offering delivers programs that enhance efficiencies and standardize processes across the healthcare system, thereby providing quality patient care.
The first proper implementation of this partnership is the Open Talent Marketplace for Healthcare, which was created to ensure access to talent for state governments, federal agencies and healthcare systems. This is especially crucial in these times as the entire healthcare community is working to meet overwhelming workforce needs due to the coronavirus pandemic. With Open Talent Marketplace, the response is swift and well-organized, providing a reliable playbook to health organizations.
Market Prospects
Per a report by Grand View Research, the global healthcare staffing market size was valued at $31.8 billion in 2019 and is expected to see a CAGR of 5.4% over the period of 2020-2027.Hence, the partnership has been inked at an ideal time.
Price Performance
In the past year, the stock has lost 14.3% compared with 25.1% decline of its industry.
Zacks Rank and Key Picks
AMN Healthcare currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are ResMed Inc. RMD, DexCom DXCM and Surmodics SRDX.
ResMed has a projected long-term earnings growth rate of 12%. It currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DexCom’s long-term earnings growth rate is estimated at 36.7%. The company presently carries a Zacks Rank #2.
Surmodics’ long-term earnings growth rate is estimated at 10%. It currently carries a Zacks Rank #2.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DexCom, Inc. (DXCM) : Free Stock Analysis Report
Surmodics, Inc. (SRDX) : Free Stock Analysis Report
ResMed Inc. (RMD) : Free Stock Analysis Report
AMN Healthcare Services Inc (AMN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
